MM&M: "How Pablo Graiver plans to solve the problem of clinical-trial recruitment"
MM&M recently interviewed our CEO, Pablo Graiver, about his daily routines, how he started Antidote, what inspires him and what he's looking forward to:
"How did you get into the industry?
I grew up in Argentina and had a good friend who was a physician. I would ride my bike to the local hospital to shadow her, and it started a lifelong love of medicine. Eventually, I became an internet entrepreneur.
Fast forward to a glass of wine in London with the same physician friend, who is now a cardiologist. I was itching to start something new, so I asked her, “What is the biggest issue in healthcare today?” She spelled it out for me: While clinical trials are vital to the development of new treatments, many fail before they even begin. Researchers struggle to find the right people to take part in their trials, while patients have no way of easily finding trials to join. I felt uniquely suited to solve this problem, with my interest in healthcare and my expertise in meta-search technology at companies like Kayak. My wheels began spinning and that's really when Antidote was born."